HemoShear Therapeutics' Series A Round

HemoShear Therapeutics raised a round of funding on , .

HemoShear Therapeutics discovers novel biological targets and advances drug programs to treat metabolic disorders with significant unmet patient need. Its proprietary drug discovery platform, REVEAL-T…

Articles about HemoShear Therapeutics' Series A Round: